Addex Therapeutics Ltd (ADXN)
15.41
-0.14
(-0.90%)
USD |
NASDAQ |
Apr 25, 11:43
Addex Therapeutics Market Cap: 16.47M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 16.62M |
| April 23, 2024 | 20.03M |
| April 22, 2024 | 20.61M |
| April 19, 2024 | 21.43M |
| April 18, 2024 | 22.40M |
| April 17, 2024 | 23.51M |
| April 16, 2024 | 24.15M |
| April 15, 2024 | 26.45M |
| April 12, 2024 | 27.33M |
| April 11, 2024 | 27.95M |
| April 10, 2024 | 29.11M |
| April 09, 2024 | 29.82M |
| April 08, 2024 | 23.35M |
| April 05, 2024 | 19.10M |
| April 04, 2024 | 17.51M |
| April 03, 2024 | 16.46M |
| April 02, 2024 | 14.15M |
| April 01, 2024 | 13.89M |
| March 28, 2024 | 13.68M |
| March 27, 2024 | 13.20M |
| March 26, 2024 | 12.88M |
| March 25, 2024 | 12.61M |
| March 22, 2024 | 12.53M |
| March 21, 2024 | 12.93M |
| March 20, 2024 | 13.04M |
| Date | Value |
|---|---|
| March 19, 2024 | 12.86M |
| March 18, 2024 | 12.80M |
| March 15, 2024 | 12.52M |
| March 14, 2024 | 11.98M |
| March 13, 2024 | 11.81M |
| March 12, 2024 | 12.50M |
| March 11, 2024 | 12.57M |
| March 08, 2024 | 12.29M |
| March 07, 2024 | 10.09M |
| March 06, 2024 | 9.715M |
| March 05, 2024 | 10.01M |
| March 04, 2024 | 10.68M |
| March 01, 2024 | 9.673M |
| February 29, 2024 | 10.16M |
| February 28, 2024 | 10.81M |
| February 27, 2024 | 10.89M |
| February 26, 2024 | 10.48M |
| February 23, 2024 | 10.25M |
| February 22, 2024 | 11.30M |
| February 21, 2024 | 11.03M |
| February 20, 2024 | 10.16M |
| February 16, 2024 | 10.97M |
| February 15, 2024 | 11.13M |
| February 14, 2024 | 11.13M |
| February 13, 2024 | 11.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.324M
Minimum
Nov 09 2023
106.92M
Maximum
Dec 24 2020
30.83M
Average
30.43M
Median
Apr 04 2022
Market Cap Benchmarks
| AC Immune SA | 227.47M |
| CRISPR Therapeutics AG | 4.489B |
| NLS Pharmaceutics Ltd | 5.207M |
| Molecular Partners AG | 127.47M |
| MoonLake Immunotherapeutics | 2.649B |
Market Cap Related Metrics
| PS Ratio | 5.337 |
| Price to Book Value | 12.08 |
| Price | 15.41 |
| Earnings Yield | -121.1% |